Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H24O |
| Molecular Weight | 184.3184 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCC=O
InChI
InChIKey=HFJRKMMYBMWEAD-UHFFFAOYSA-N
InChI=1S/C12H24O/c1-2-3-4-5-6-7-8-9-10-11-12-13/h12H,2-11H2,1H3
| Molecular Formula | C12H24O |
| Molecular Weight | 184.3184 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cell fates and fusion in the C. elegans vulval primordium are regulated by the EGL-18 and ELT-6 GATA factors -- apparent direct targets of the LIN-39 Hox protein. | 2002-11 |
|
| Protein kinase C isotypes in C. elegans. | 2002-10 |
|
| Effect of periparturient diseases accompanied by excessive vulval discharge and weaning to mating interval on sow reproductive performance. | 2002-09 |
|
| The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus. | 2002-09 |
|
| ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. | 2002-08-15 |
|
| A new tin-free source of amidyl radicals. | 2002-08-08 |
|
| The management of chronic vulval discomfort in Australia. | 2002-08 |
|
| The role of p53 and Ki67 in Paget's disease of the vulva and the breast. | 2002-08 |
|
| C. elegans EOR-1/PLZF and EOR-2 positively regulate Ras and Wnt signaling and function redundantly with LIN-25 and the SUR-2 Mediator component. | 2002-07-15 |
|
| Downstream targets of let-60 Ras in Caenorhabditis elegans. | 2002-07-01 |
|
| Tissue-specific regulation of the LIM homeobox gene lin-11 during development of the Caenorhabditis elegans egg-laying system. | 2002-07-01 |
|
| CO(2) laser therapy of vulval lymphangiectasia and lymphangioma circumscriptum. | 2002-07 |
|
| MAP kinase phosphatases. | 2002-06-26 |
|
| The Caenorhabditis elegans gene, gly-2, can rescue the N-acetylglucosaminyltransferase V mutation of Lec4 cells. | 2002-06-21 |
|
| C. elegans class B synthetic multivulva genes act in G(1) regulation. | 2002-06-04 |
|
| Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. | 2002-06-01 |
|
| Premalignant vulval disorders. | 2002-06 |
|
| The complexities of female sexual arousal disorder: potential role of pharmacotherapy. | 2002-06 |
|
| National guideline on the management of vulval conditions. | 2002-06 |
|
| Activation of Wnt signaling bypasses the requirement for RTK/Ras signaling during C. elegans vulval induction. | 2002-05-15 |
|
| Vulval squamous cell carcinoma arising in localized Darier's disease. | 2002-05-10 |
|
| Lipid A structure of Pseudoalteromonas haloplanktis TAC 125: use of electrospray ionization tandem mass spectrometry for the determination of fatty acid distribution. | 2002-05 |
|
| A lin-45 raf enhancer screen identifies eor-1, eor-2 and unusual alleles of Ras pathway genes in Caenorhabditis elegans. | 2002-05 |
|
| The C. elegans evl-20 gene is a homolog of the small GTPase ARL2 and regulates cytoskeleton dynamics during cytokinesis and morphogenesis. | 2002-05 |
|
| A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. | 2002-05 |
|
| Vulval disease from the 1800s to the new millennium. | 2002-04-16 |
|
| Localization of mLin-7 at nectin-based cell-cell junctions. | 2002-04-11 |
|
| Case study: chronic erysipelas of the sow--a subclinical manifestation of reproductive problems. | 2002-04 |
|
| Inhibition of cytopathic effect of human immunodeficiency virus type-1 by various phorbol derivatives. | 2002-04 |
|
| The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia. | 2002-04 |
|
| Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. | 2002-03-24 |
|
| Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia. | 2002-03-14 |
|
| Analysis of CHK2 in vulval neoplasia. | 2002-03-04 |
|
| Antimicrobial activity of 9-O-acyl- and 9-O-alkylberberrubine derivatives. | 2002-03 |
|
| Topical anesthesia for minor gynecological procedures: a review. | 2002-03 |
|
| A heterochromatin protein 1 homologue in Caenorhabditis elegans acts in germline and vulval development. | 2002-03 |
|
| The Caenorhabditis elegans histone hairpin-binding protein is required for core histone gene expression and is essential for embryonic and postembryonic cell division. | 2002-02-15 |
|
| High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999. | 2002-02 |
|
| Caenorhabditis elegans lin-45 raf is essential for larval viability, fertility and the induction of vulval cell fates. | 2002-02 |
|
| The T-box factor MLS-1 acts as a molecular switch during specification of nonstriated muscle in C. elegans. | 2002-01-15 |
|
| Is there a link between vulval cancer and blood group? | 2002 |
|
| P27 expression in normal epithelium and condylomas of the vulva in HIV positive and negative women. | 2002 |
|
| Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins. | 2002 |
|
| Vulval disease in pre-pubertal girls. | 2001-11 |
|
| The Laugier-Hunziker syndrome. | 2001-11 |
|
| An uncommon cause of a destructive vulval lesion. | 2001-11 |
|
| Artificial inseminations with frozen semen and application of DNA fingerprint for parents/offspring conformation on Great Pyrenees. | 2001 |
|
| Conserved cellular and molecular mechanisms in development. | 2001 |
|
| Vulval intraepithelial neoplasia: current perspectives. | 2001 |
|
| Development of an optimized interaction-mating protocol for large-scale yeast two-hybrid analyses. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 18:07:02 GMT 2025
by
admin
on
Wed Apr 02 18:07:02 GMT 2025
|
| Record UNII |
C42O120SEF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
128949
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
||
|
JECFA EVALUATION |
LAURIC ALDEHYDE
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
||
|
CFR |
21 CFR 172.515
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000162880
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
C42O120SEF
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
DODECANAL
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
27836
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
C42O120SEF
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
8194
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
203-983-6
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
46128
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
SUB176897
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
DTXSID6021589
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
112-54-9
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | |||
|
1312621
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY | RxNorm | ||
|
262
Created by
admin on Wed Apr 02 18:07:02 GMT 2025 , Edited by admin on Wed Apr 02 18:07:02 GMT 2025
|
PRIMARY |